A California-based startup called R3 Bio has disclosed details about its controversial research after years of operating in secrecy, revealing plans to create nonsentient monkey "organ sacks" as an alternative to conventional animal testing.

The Richmond, California-based company announced last week that it had secured funding for the project, which aims to develop organisms without consciousness that could serve as testing platforms for medical research. The startup described these creations as lacking sentience while maintaining biological functions needed for research purposes.

According to an interview with Wired, R3 Bio identified three key investors backing the venture: billionaire Tim Draper and Singapore-based fund Immortal, among others. The company had previously kept its research activities and funding sources confidential.

The announcement represents a significant development in the field of alternative testing methods, as researchers and companies seek ways to reduce reliance on traditional animal testing while maintaining the ability to conduct necessary medical research. The concept of creating nonsentient biological organisms specifically for research purposes raises both scientific and ethical questions about the future of laboratory testing.

R3 Bio's emergence from stealth mode signals the company's readiness to move forward with its research plans, though specific timelines for implementation were not disclosed in the initial announcement.